Omeros
OMER
18.75
+0.24
+1.30%
Omeros
US · OMER
#3062 by market cap
Listed 1970
18.75
+0.24
+1.30%
Live - 5344 symbols - heartbeat 186s ago
· 2026-10-08 06:36
Pre-market
18.55
-1.07%
After-hours
18.84
+0.48%
- Market cap
- 1.36B
- P/E (TTM)i
- 10.84
- P/Bi
- -26.45
- EPSi
- -0.05
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on OMER?
Anonymous reader poll. Unscientific, not investment advice.
About Omeros
Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
- Founded
- 1994
- CEO
- Dr. Gregory A. Demopulos,M.D.
- Employees
- 175
- Headquarters
- Seattle, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- omeros.com
Company profile
- Exchange
- US
- Symbol
- OMER
- Market-cap rank
- #3062
- Listing date
- 1970-01-01
- Market cap
- 1.36B
- Float cap
- 1.30B
- Shares out
- 72.39M
- Float shares
- 69.29M
Sectors & themes
Quote time 2026-10-08 06:36:11 · For reference only, not investment advice and not tailored to your situation.